Journals / Turkish Journal of Chemistry / 2008 / Cilt: 32 - Sayı: 5

The Synthesis and Antimicrobial Activity of \\\g-Butyrolactone Derivatives

Pages
615–621
DOI
—

Abstract

This paper examines the synthesis of g-butyrolactone compounds 2, 3, 4, 5, and 9, and their potential antimicrobial nature and ability. The structures of all the compounds mentioned above were determined and confirmed with elemental analyses, and IR, 1H-NMR, and 13C-NMR spectroscopy. The in vitro antimicrobial activity of compounds 2, 3, 4, 5, and 9 was examined and evaluated against the following pathogens: Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, Aspergillus niger, and Candida albicans. Compound 5 (20 mg/mL) demonstrated high antimicrobial activity against S. epidermidis, which was closely comparable to the antimicrobial activity of streptomycin.

Özet

This paper examines the synthesis of g-butyrolactone compounds 2, 3, 4, 5, and 9, and their potential antimicrobial nature and ability. The structures of all the compounds mentioned above were determined and confirmed with elemental analyses, and IR, 1H-NMR, and 13C-NMR spectroscopy. The in vitro antimicrobial activity of compounds 2, 3, 4, 5, and 9 was examined and evaluated against the following pathogens: Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, Aspergillus niger, and Candida albicans. Compound 5 (20 mg/mL) demonstrated high antimicrobial activity against S. epidermidis, which was closely comparable to the antimicrobial activity of streptomycin.